ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
josiejow37
|
17 |
4.3K |
7 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
17
|
4.3K
|
7
|
|
Charts
|
RHY |
Re:
RHY charts
|
|
josiejow37
|
80 |
45K |
0 |
23/01/23 |
23/01/23 |
Charts
|
80
|
45K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
josiejow37
|
17 |
4.3K |
8 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
17
|
4.3K
|
8
|
|
ASX - By Stock
|
RHY |
Re:
CSIRO National Library of Medicine article from 2015
|
|
josiejow37
|
5 |
1.6K |
3 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
5
|
1.6K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
CSIRO National Library of Medicine article from 2015
|
|
josiejow37
|
5 |
1.6K |
2 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
5
|
1.6K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
2 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
22
|
4.7K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
4 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
22
|
4.7K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
12 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
22
|
4.7K
|
12
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
11 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
22
|
4.7K
|
11
|
|
ASX - By Stock
|
RHY |
CSIRO National Library of Medicine article from 2015
|
|
josiejow37
|
5 |
1.6K |
10 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
5
|
1.6K
|
10
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
5 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
22
|
4.7K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
6 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
22
|
4.7K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
3 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
22
|
4.7K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
0 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
22
|
4.7K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
0 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
22
|
4.7K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Bescreened 10,000 patient tests /trial
|
|
josiejow37
|
22 |
4.7K |
2 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
22
|
4.7K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
BeScreened
|
|
josiejow37
|
39 |
7.0K |
5 |
15/01/23 |
15/01/23 |
ASX - By Stock
|
39
|
7.0K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
BeScreened
|
|
josiejow37
|
39 |
7.0K |
6 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
39
|
7.0K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
BeScreened
|
|
josiejow37
|
39 |
7.0K |
7 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
39
|
7.0K
|
7
|
|
ASX - By Stock
|
RHY |
Re:
BeScreened
|
|
josiejow37
|
39 |
7.0K |
8 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
39
|
7.0K
|
8
|
|
ASX - By Stock
|
RHY |
Re:
BeScreened
|
|
josiejow37
|
39 |
7.0K |
10 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
39
|
7.0K
|
10
|
|
ASX - By Stock
|
RHY |
Re:
Ann: MST Access Financial Diagnostics Presentation
|
|
josiejow37
|
51 |
16K |
2 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
51
|
16K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: MST Access Financial Diagnostics Presentation
|
|
josiejow37
|
51 |
16K |
3 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
51
|
16K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
2 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
24
|
7.1K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Superior CRC Blood test than COLOSTAT
|
|
josiejow37
|
4 |
1.3K |
3 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
4
|
1.3K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
6 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
24
|
7.1K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
5 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
24
|
7.1K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
3 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
24
|
7.1K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
4 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
24
|
7.1K
|
4
|
|
ASX - By Stock
|
RHY |
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
9 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
24
|
7.1K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
1 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
74
|
19K
|
1
|
|
Charts
|
RHY |
Re:
RHY charts
|
|
josiejow37
|
80 |
45K |
1 |
30/12/22 |
30/12/22 |
Charts
|
80
|
45K
|
1
|
|
Charts
|
RHY |
Re:
RHY charts
|
|
josiejow37
|
80 |
45K |
1 |
30/12/22 |
30/12/22 |
Charts
|
80
|
45K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
2 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
74
|
19K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
1 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
74
|
19K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
6 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
74
|
19K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
2 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
74
|
19K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
3 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
74
|
19K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
6 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
74
|
19K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
5 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
74
|
19K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
12 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
74
|
19K
|
12
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
0 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
52
|
13K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
4 |
27/12/22 |
27/12/22 |
ASX - By Stock
|
52
|
13K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
3 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
52
|
13K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
4 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
52
|
13K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
6 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
52
|
13K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
1 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
52
|
13K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
2 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
52
|
13K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
4 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
52
|
13K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Why isn't Colostat being sold into European markets and NZ?
|
|
josiejow37
|
52 |
13K |
0 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
52
|
13K
|
0
|
|